Is NURO a good stock to own? Find out who bought NeuroMetrix, who sold NeuroMetrix (NURO) stock, and who holds a large position in NeuroMetrix.

• NEA Management Company owns 57273 shares worth $140891

• Cacti Asset Management sold on Sept. 30, 2011
• T. Rowe Price Associates sold on Aug. 12, 2011
• GRT Capital Partners sold on June 30, 2011
• GMT Capital sold on June 30, 2011
• D. E. Shaw & Co sold on June 30, 2011
• CalPERS sold on June 30, 2011
• Vanguard sold on June 30, 2011
• Johnson Investment Counsel sold on June 30, 2011
• Gabelli Securities sold on June 30, 2011
• Rima Management sold on June 30, 2011
• Wells Fargo & Company sold on March 31, 2011
• Knight Capital sold on Dec. 31, 2010
• Janney Montgomery Scott sold on Dec. 31, 2010
• UBS AG sold on Dec. 31, 2010
• Public Employees' Retirement Association of Colorado sold on Sept. 30, 2010
• Manulife Asset Management sold on Dec. 31, 2007
• Manulife Asset Management sold on Dec. 31, 2007
• Zebra Capital Management sold on June 30, 2007
• Tradeworx sold on Dec. 31, 2006
• Navellier & Associates sold on June 30, 2006

• InterMune (ITMN)
• ArQule (ARQL)
• Exelixis (EXEL)
• Nektar Therapeutics (NKTR)
• Rigel Pharmaceuticals (RIGL)
• Lexicon Pharmaceuticals (LXRX)
• Targacept (TRGT)
• NeuroMetrix (NURO)
• Solta Medical (SLTM)
• Sunesis Pharmaceuticals (SNSS)
• Zhone Technologies (ZHNE)
• Amicus Therapeutics (FOLD)
• Cadence Pharmaceuticals (CADX)
• Transcept Pharmaceuticals (TSPT)
• Alimera Sciences (ALIM)
• Glu Mobile (GLUU)